Assignee
KITE PHARMA INC
US·48 granted patents·79 pending applications·188 citations·filing 2016–2025
Top patents by PatentIndex Score
127 records- 0195US10626187B2Antigen binding molecules specific for an anti-CD19 scFvKITE PHARMA INC·Filed 2017·Granted Apr 21, 2020·8 cites·12 claims
- 0295US10603380B2Chimeric antigen and T cell receptors and methods of useKITE PHARMA INC·Filed 2017·Granted Mar 31, 2020·16 cites·27 claims
- 0395US10322146B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2017·Granted Jun 18, 2019·17 cites·30 claims
- 0495US9855298B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2016·Granted Jan 2, 2018·80 cites·30 claims
- 0593US10844120B2Humanized antigen-binding domains and methods of useKITE PHARMA INC·Filed 2018·Granted Nov 24, 2020·8 cites·15 claims
- 0692US10844371B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2018·Granted Nov 24, 2020·6 cites·9 claims
- 0790US11572388B2Chimeric polypeptides and uses thereofKITE PHARMA INC·Filed 2020·Granted Feb 7, 2023·2 cites·7 claims
- 0890US11384155B2Antigen binding molecules specific for an anti-CD19 scFvKITE PHARMA INC·Filed 2020·Granted Jul 12, 2022·2 cites·12 claims
- 0990US11046775B2CD70 binding molecules and methods of use thereofKITE PHARMA INC·Filed 2018·Granted Jun 29, 2021·9 cites·50 claims
- 1089US11779601B2Diagnostic methods for T cell therapyKITE PHARMA INC·Filed 2016·Granted Oct 10, 2023·5 cites·13 claims
- 1188US2025243295A1Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 1287US11491187B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2018·Granted Nov 8, 2022·2 cites·15 claims
- 1386US10597456B2Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2017·Granted Mar 24, 2020·6 cites·46 claims
- 1485US11834654B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2020·Granted Dec 5, 2023·1 cites·5 claims
- 1585US2025367221A1Methods of conditioning patients for t cell therapyKITE PHARMA INC·Filed 2025·Application pending·0 cites
- 1684USD991483SCassette foam insertKITE PHARMA INC·Filed 2021·Granted Jul 4, 2023·10 cites·1 claims
- 1784US10501775B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2017·Granted Dec 10, 2019·6 cites·20 claims
- 1883US11723923B2Methods of preparing T cells for T cell therapyKITE PHARMA INC·Filed 2019·Granted Aug 15, 2023·2 cites·12 claims
- 1983US11608517B2Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2019·Granted Mar 21, 2023·2 cites·15 claims
- 2082US12583923B2Chimeric antigen and T cell receptors and methods of useKITE PHARMA INC·Filed 2024·Granted Mar 24, 2026·0 cites·29 claims
- 2182US2025243258A1Chimeric receptor t cell treatment using characteristics of the tumor microenvironmentKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 2281US12458654B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2022·Granted Nov 4, 2025·0 cites·12 claims
- 2381US12404305B2Chimeric polypeptides and uses thereofKITE PHARMA INC·Filed 2022·Granted Sep 2, 2025·0 cites·4 claims
- 2481US12202909B2Antigen binding molecules specific for an anti-CD19 scFVKITE PHARMA INC·Filed 2022·Granted Jan 21, 2025·0 cites·9 claims
- 2581US2024158748A1Methods for producing autologous t cells useful to treat b cell malignancies and other cancers and compositions thereofKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 2681US2025002851A1Methods of preparing t cells for t cell therapyKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 2780US11390655B2Modified chimeric antigen receptors and methods of useKITE PHARMA INC·Filed 2018·Granted Jul 19, 2022·1 cites·6 claims
- 2879US11708401B2Chimeric transmembrane proteins and uses thereofKITE PHARMA INC·Filed 2019·Granted Jul 25, 2023·2 cites·20 claims
- 2979US10689450B2BCMA binding molecules and methods of use thereofKITE PHARMA INC·Filed 2017·Granted Jun 23, 2020·1 cites·71 claims
- 3078US2024009243A1Methods of preparing t cells for t cell therapyKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 3177US12109235B2TGF-beta receptors and methods of useKITE PHARMA INC·Filed 2020·Granted Oct 8, 2024·1 cites·11 claims
- 3277US2024150750A1Antigen binding molecules and methods of use thereofKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 3377US2025188177A1Cd70 binding molecules and methods of use thereofKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 3476US12559718B2Diagnostic methods for t cell therapyKITE PHARMA INC·Filed 2023·Granted Feb 24, 2026·0 cites·30 claims
- 3575US11793834B2Chimeric antigen and T cell receptors and methods of useKITE PHARMA INC·Filed 2019·Granted Oct 24, 2023·1 cites·17 claims
- 3674US2024115611A1Chimeric antigen and t cell receptors and methods of useKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 3773US12459979B2Modified chimeric antigen receptors and methods of useKITE PHARMA INC·Filed 2022·Granted Nov 4, 2025·0 cites·6 claims
- 3873US2022265721A1Treatment using chimeric receptor t cells incorporating optimized polyfunctional t cellsKITE PHARMA INC·Filed 2022·Application pending·0 cites
- 3973US2023331855A1Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 4073US2024168016A1Flow cytometric method for characterization of t-cell impuritiesKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 4173US2023146195A1Bcma binding molecules and methods of use thereofKITE PHARMA INC·Filed 2022·Application pending·0 cites
- 4271US11505613B2BCMA binding molecules and methods of use thereofKITE PHARMA INC·Filed 2019·Granted Nov 22, 2022·0 cites·22 claims
- 4370US12180292B2CD70 binding molecules and methods of use thereofKITE PHARMA INC·Filed 2021·Granted Dec 31, 2024·0 cites·17 claims
- 4469US2024058381A1Methods of administering chimeric antigen receptor immunotherapyKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 4569US2025109182A1TGF-beta Receptors and Methods of UseKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 4668US12156887B2Chimeric receptor T cell treatment using characteristics of the tumor microenvironmentKITE PHARMA INC·Filed 2019·Granted Dec 3, 2024·0 cites·6 claims
- 4768US2022249631A1Methods and systems for performing a patient-specific immunotherapy procedure with chain-of-custody and chain-of-identity biological sample trackingKITE PHARMA INC·Filed 2022·Application pending·0 cites
- 4867US2024091261A1Immune cell functionKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 4967US2023270785A1Methods of administering chimeric antigen receptor immunotherapyKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 5066US12480951B2Methods and compositions for T cell therapyKITE PHARMA INC·Filed 2022·Granted Nov 25, 2025·0 cites·15 claims
Showing the top 50 of 127 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →